Commentary: Advances in Glioblastoma Therapies: A Collaborative Effort Between Physicians and the Biotechnology Industry

Neurosurgery. 2018 Oct 1;83(4):E162-E168. doi: 10.1093/neuros/nyy253.

Authors

Julia R Schneider^{1

2}, Kay O Kulason¹, Muhammad Babar Khan², Timothy G White¹, Kevin Kwan^{1

2}, Lukas Faltings¹, Andrew J Kobets², Shamik Chakraborty^{1

2}, Jason A Ellis^{1

2}, Rafael A Ortiz^{1

2}, Christopher G Filippi^{2

3}, David J Langer^{1

2}, John A Boockvar^{1

2}

Affiliations

¹ Brain Tumor Biotech Center, Department of Neurosurgery, Lenox Hill Hospital, Zucker School of Medicine at Hofstra/Northwell, New York, New York.
² Feinstein Institute for Medical Research, Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York.
³ Department of Neuroradiology, Lenox Hill Hospital, Zucker School of Medicine at Hofstra/Northwell, New York, New York.

PMID: 29889276
DOI: 10.1093/neuros/nyy253

No abstract available